Gambling Funding and the Trust Problem
You can fund safer gambling work and still get accused of buying influence. You can refuse industry money and still face the hard question of who pays. That is the bind around gambling funding right now, and it matters because treatment, research, education, and prevention all need steady money. The old voluntary model gave operators room to show willing, but it also left critics asking whether the funder had too much sway over the work. The shift toward statutory levies, especially in the UK, is meant to answer that charge. But law does not erase politics. It only moves the fight to a different table. As iGaming Business has reported, the sector faces a “damned if you do, damned if you don’t” problem. I have covered this industry long enough to know one thing: vague goodwill will not survive public scrutiny.
What to watch now
- Voluntary funding has a trust deficit, even when the money supports useful treatment or research.
- Statutory levies can improve independence, but only if allocation rules are clear and public.
- Operators still need a role in data access, product design, and harm prevention, not in steering findings.
- Researchers and charities need stable funding, or safer gambling work becomes stop-start and weaker.
Why gambling funding became so toxic
The core issue is simple. Gambling companies profit from gambling activity, including activity that can cause harm. So when those same companies fund harm-reduction work, critics see a conflict of interest.
That suspicion is not irrational. Public health has lived through tobacco, alcohol, and fossil fuel fights, where industry-backed research often became a political weapon. Gambling is not identical to those sectors, but the public memory is there. Once trust is gone, even good-faith funding looks tainted.
Look, the operator view is also easy to understand. If your business creates a risk, should you not help pay for the safety net? Refusing money from the industry can sound principled, until treatment providers ask how they are meant to hire clinicians next quarter.
Money is not neutral in gambling policy. The test is whether funders can influence priorities, data, messaging, or outcomes.
Gambling funding models: voluntary cash versus statutory levy
The voluntary model gave operators flexibility. Many paid into research, education, and treatment bodies, often through groups such as GambleAware in the UK. Some paid more than others. Some paid late. Some paid little enough to invite public criticism.
A statutory levy changes the baseline. Operators must pay according to rules set by government or regulator, and the money can be routed through public bodies or independent commissioners. In the UK, the government’s gambling reform agenda has pushed this approach because voluntary donations could not shake the perception problem.
Would a levy fix everything?
No.
A levy can answer the “who pays” question, but it still leaves the harder ones. Who decides research priorities? Who controls access to operator data? How are treatment outcomes measured? And what happens if politically useful projects get funded while uncomfortable work gets parked?
What a solid levy needs
- Transparent rates: Operators should know what they owe and why rates differ by product risk, channel, or margin.
- Independent allocation: Funding decisions should sit away from operator lobbying and short-term political noise.
- Published grants: Every recipient, amount, and project goal should be visible.
- Outcome tracking: Treatment and prevention work should be judged on evidence, not press releases.
- Data access rules: Researchers need usable industry data, with privacy protections and no operator veto.
The operator dilemma in gambling funding
Operators cannot wash their hands of harm reduction. That would be a bad look and bad policy. But they also should not sit too close to the research agenda.
The clean split is this: companies pay, public or independent bodies allocate, researchers publish without approval gates. Operators can provide data, technical context, and access to product teams. They should not get to soften language, delay reports, or choose which findings reach the public.
Think of it like professional football funding concussion research. Clubs should pay into the system because their sport creates the risk, but they should not get to mark the medical papers before publication. Same principle, different pitch.
What researchers need from gambling funding
Researchers need more than a cheque. They need multi-year commitments, raw but protected data, and freedom to publish negative findings. Short grants can produce tidy reports, but they rarely track harm over time.
Good gambling research also needs product-level detail. Broad surveys help, but they cannot fully explain how online slots design, bonus mechanics, in-play betting, VIP programs, or affordability checks affect behavior. Without that detail, policy becomes guesswork with footnotes.
There is a catch (there always is). The more useful the data, the more sensitive it becomes. That means regulators must set strict privacy rules, secure access systems, and penalties for misuse. Otherwise, operators will have an easy excuse to keep the best data locked away.
Why treatment providers are stuck in the middle
Treatment bodies get pulled into a fight they did not create. If they take industry-linked money, some critics question their independence. If they refuse it, they may lose the capacity to help people now.
That trade-off is brutal. Problem gambling treatment needs trained staff, referral routes, digital support, and links with mental health services. It also needs continuity. You cannot build a credible support network on annual uncertainty and moral arguments alone.
The better answer is ring-fenced public commissioning, funded by the industry through a levy. That gives providers distance from operators while keeping the cost where it belongs. It also lets the public compare services by waiting times, completion rates, relapse support, and patient feedback.
How regulators should judge gambling funding
Regulators should stop treating funding as a reputational side issue. It is part of the safer gambling system. If money flows badly, evidence gets weaker, treatment gets patchier, and public confidence drops.
A practical regulator checklist would ask:
- Does the funding model reduce conflicts of interest?
- Are decisions visible enough for public challenge?
- Does money reach prevention, treatment, and independent research?
- Can researchers publish findings without funder approval?
- Are high-risk products paying enough compared with lower-risk activity?
The last point matters. A flat funding model can look fair on paper while ignoring product risk. Online casino, sports betting, bingo, lottery, and land-based venues do not carry identical risk profiles. Policy should not pretend they do.
Gambling funding still needs industry data
Here is the awkward bit. Even the cleanest public funding model still needs cooperation from gambling companies. Regulators and researchers need transaction data, account histories, intervention records, and product information to understand harm patterns.
That does not mean operators should own the process. It means data-sharing duties should be written into licence conditions. The Gambling Commission and other regulators already ask for large amounts of compliance data. The next step is making research-grade access normal, secure, and enforceable.
Honestly, this is where the debate often gets too theatrical. People argue about whether industry money is dirty, then ignore the fact that industry systems hold much of the evidence needed to reduce harm. You can dislike that reality. You still have to deal with it.
The test is independence, not purity
The cleanest policy position is not “take no gambling money ever.” It is “take the money through a structure that blocks influence.” That means statutory collection, independent commissioning, open reporting, and hard rules on publication rights.
For operators, the message is uncomfortable but clear. Paying more will not buy trust by itself. If the sector wants credibility, it has to accept distance from the work it funds. No quiet edits. No friendly research pipelines. No selective enthusiasm for findings that suit commercial goals.
For policymakers, the next move is just as plain: build a funding system that can survive hostile questions in public. If it cannot do that, the argument will keep circling back to the same place, and people who need help will be left waiting while everyone else fights over the receipt.
